Federated Hermes Adds $14M in BrightSpring Health Services, Inc. ($BTSG)
Federated Hermes increased its position in BrightSpring Health Services by 20.5%, according to a recent 13F filing.
Key Points
- Federated Hermes increased its stake in BrightSpring Health Services by 20.5%, adding 203,321 shares for a total of 1,195,723 shares valued at $83.3 million.
- Shares of BrightSpring Health Services traded near $69.70 on Friday, with a market cap of about $13.68 billion and a forward P/E of 32.94.
- Insider transactions include a sale by CEO Jon Rousseau of 260,000 shares, and analysts like BTIG and TD Cowen maintain a 'buy' rating with targets up to $90.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Federated Hermes has increased its investment in BrightSpring Health Services, Inc. (NasdaqGS: BTSG) by 20.5%, according to its latest 13F filing with the SEC. The fund added 203,321 shares, bringing its total holdings to 1,195,723 shares valued at approximately $83.3 million. This filing reflects holdings as of the end of the reporting period and may not represent the investor's current position.
Federated Hermes vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
What Changed in Federated Hermes's BrightSpring Health Services Position
Federated Hermes grew its stake in BrightSpring Health Services by 20.5%, adding 203,321 shares to its portfolio. This brings its total holdings to 1,195,723 shares, valued at about $83.3 million.
Other Institutional Activity in BrightSpring Health Services
Several other institutional investors also adjusted their positions in BrightSpring Health Services. BlackRock, Inc. increased its holdings by 2,615,897 shares, ending with 19,602,159 shares valued at approximately $835.2 million, a 15.4% increase. Invesco Ltd. added 886,924 shares, bringing its total to 11,482,156 shares worth $489.3 million, marking an 8.4% rise. Meanwhile, Kohlberg Kravis Roberts & Co. L.P. reduced its stake by 20,117,773 shares, a 32.5% decrease, leaving it with 41,824,259 shares valued at $1.78 billion. Vanguard Portfolio Management LLC initiated a new position with 8,032,770 shares worth about $342.3 million.
BrightSpring Health Services, Inc. Stock Up 17.9%
Shares of BrightSpring Health Services traded near $69.70 on Friday. The company has a market cap of approximately $13.68 billion, with a P/E ratio of 90.52 and a forward P/E of 32.94. Its beta stands at 1.874, indicating higher volatility compared to the market. The stock's 52-week range is between $19.01 and $69.89, with a 50-day moving average of $56.66 and a 200-day moving average of $41.39. BrightSpring's liquidity is supported by a current ratio of 1.737 and a quick ratio of 1.356, while its debt-to-equity ratio is 135.679.
$BTSG stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
BrightSpring Health Services reported revenue of $13.65 billion, showing a growth of 25.6%. The company achieved an EPS of $0.77, with a net margin of 2.27% and a return on equity of 9.23%. The next earnings report is expected on July 31, 2026.
Insider Buying and Selling at BrightSpring Health Services, Inc.
Several insider transactions were reported at BrightSpring Health Services. On June 5, 2026, CEO Jon Rousseau sold 260,000 shares, while Chief of Staff and Senior Vice President Lisa Nalley sold 35,000 shares at an average price of $58.75. On June 11, 2026, Nigam Shah purchased 4,013 shares. On June 20, 2026, Scott Greenwell, President of PharMerica, sold 2,487 shares at $66.25.
Analysts Set New Price Targets
Analysts have been active in setting new price targets for BrightSpring Health Services. On June 22, 2026, BTIG maintained its 'buy' rating with a $90 price target. TD Cowen, on June 18, 2026, also maintained a 'buy' rating with an $81 target. Goldman Sachs initiated coverage with a 'buy' rating and a $71 target on June 8, 2026. The consensus among 16 analysts is a 'strong buy' with a mean target price of $66.31.
About BrightSpring Health Services
BrightSpring Health Services, Inc. is a healthcare services company based in Louisville, Kentucky. It provides home and community-based health services across the United States, focusing on pharmacy solutions and provider services. The company offers clinical and supportive care in home settings to Medicare, Medicaid, and insured populations. BrightSpring also provides a range of rehabilitation services. Founded in 1974, it employs approximately 23,500 people and is led by CEO Jon B. Rousseau.
Bottom Line
Federated Hermes's increased stake in BrightSpring Health Services suggests confidence in the company's potential. Investors keep an eye on such 13F filings to gauge institutional sentiment. As always, these filings reflect past holdings and may not indicate current positions.
Get BrightSpring Health Services, Inc. alerts
New 13F filings, insider trades, and analyst moves on $BTSG, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.